DEF: Nature's Sunshine Products Sets Date for 2025 Annual Shareholder Meeting

Sentiment:

Proxy Statement


Nature's Sunshine Products will hold its 2025 Annual Meeting of Shareholders on April 30, 2025, to elect directors, approve executive compensation, and ratify the appointment of its independent accounting firm.

Summary

  • Nature's Sunshine Products, Inc. will hold its 2025 Annual Meeting of Shareholders on April 30, 2025, at its principal executive offices in Lehi, Utah.
  • Shareholders of record as of February 21, 2025, are entitled to vote on the election of eight directors, an advisory resolution on executive compensation, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2025.
  • The Board of Directors recommends voting 'For' all nominees for director and 'For' the advisory resolution on executive compensation and the ratification of the accounting firm.
  • The company's 2024 performance highlights include net sales of $454.4 million, net income of $7.9 million, and adjusted EBITDA of $40.3 million.
  • The proxy materials are being sent to shareholders on or about March 20, 2025.
  • The company's Board consists of a majority of independent directors and has four standing committees: Audit, Compensation, Governance, and Risk Management.
  • The company has stock ownership guidelines for directors and executive officers and prohibits hedging, pledging, and short sales of company stock.

Sentiment

Score: 7

Explanation: The document is generally positive, outlining the company's plans for the annual meeting and highlighting some positive financial results. However, it also acknowledges certain challenges and risks, resulting in a moderately positive sentiment score.

Positives

  • The Board is composed of experienced and qualified individuals, with a majority being independent.
  • The company has established corporate governance guidelines and a code of ethics to ensure ethical business conduct.
  • The company's compensation programs are designed to reward performance and align with shareholder value creation.
  • The company has stock ownership guidelines for directors and executive officers, promoting long-term alignment with shareholders.
  • The company's Audit Committee is comprised of independent directors and financial experts.
  • The company's compensation committee has from time to time retained the services of Fredric W. Cook & Co., Inc. ('F.W. Cook'), a leading compensation consulting firm, to provide advice and recommendations regarding the Company's compensation programs, including equity compensation practices and cash compensation structure for executive officers.

Negatives

  • Richard Moss will not stand for re-election at the Annual Meeting.
  • Christopher Teets will not stand for re-election at the Annual Meeting due to the Company's Corporate Governance Guidelines and his completion of years of service on the Board.
  • Due to a recent increase in director grant values, and a drop in stock price, some directors have fallen out of compliance with the stock ownership guidelines.

Risks

  • The document includes forward-looking statements that are subject to risks and uncertainties.
  • The company's performance is subject to various internal and external risks, including legal and regulatory requirements, distributor compliance, and cybersecurity threats.
  • The company's compensation programs could potentially encourage excessive risk-taking, although the company believes this is unlikely.

Future Outlook

The document contains forward-looking statements relating to the company's objectives, plans, and strategies, which are subject to risks and uncertainties.

Management Comments

  • Terrence Moorehead, President and Chief Executive Officer, expresses pleasure in inviting shareholders to the 2025 Annual Meeting and encourages them to vote.
  • The Compensation Committee and Management are focused on a compensation structure that is competitive and fair and focuses on performance rather than entitlements.

Industry Context

Nature's Sunshine Products operates in the consumer products and direct selling industry, facing competition from other companies in the specialty retail and personal product sectors.

Comparison to Industry Standards

  • The Compensation Committee engaged F.W. Cook to conduct a study with a peer group consisting of 15 publicly traded U.S. based specialty retail and personal product companies to perform new market comparisons of our executive compensation program and to prepare its 2022 Executive Compensation Report for setting 2022, 2023 and 2024 compensation.
  • The companies in the peer group were chosen in consultation with the Compensation Committee based on objective industry classifications, annual revenue and market capitalization during 2020 (the time at which they made pay decisions disclosed in the compensation section of their 2021 proxy statements).

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman of the BoardRichard MossTBDFollowing the Annual MeetingMr. Moss's decision not to stand for re-election
DirectorChristopher TeetsTBDFollowing the Annual MeetingCompletion of years of service on the Board

Stakeholder Impact

  • Shareholders are encouraged to participate in the Annual Meeting and vote on the proposals.
  • The company's performance and governance practices impact its employees, customers, and other stakeholders.

Next Steps

  • Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The company will hold its Annual Meeting of Shareholders on April 30, 2025.
  • The Board will consider the outcome of the advisory vote on executive compensation when making future compensation decisions.

Key Dates

DateDescription
2007-02-02Deloitte & Touche LLP engaged as independent registered public accounting firm
2012-08-01Shareholders approved the Amended and Restated Natures Sunshine Products, Inc. 2012 Stock Incentive Plan
2015-01-14Shareholders approved an amendment to the 2012 Incentive Plan to increase the number of shares available for issuance
2017-06Robert Straus appointed as Director
2018-10-01Terrence Moorehead appointed as President and Chief Executive Officer
2020-07Heidi Wissmiller appointed as Director
2022-01Curtis Kopf appointed as Director
2022-05Martin Gonzalez appointed as Executive Vice President of Global Supply Chain Operations
2022-06Rong Yang appointed as Director
2022-12Shane Jones appointed the Company's Executive Vice President, Chief Financial Officer
2023-06Kevin Herbert joined Natures Sunshine as Executive Vice President, President North America
2024-03-11Time-based Restricted Stock Units (RSU) were granted to our NEOs
2024-05-06The Board approved a grant of 5,236 RSUs for each non-executive director
2024-09Kevin Fuller named Global Chief Marketing Officer of the Company
2024-11Steven Fasching appointed to the Board
2025-01Katie May appointed to the Board
2025-02-04Richard Moss notified the Board of his decision not to stand for re-election at the Annual Meeting
2025-02-21Record date for the Annual Meeting
2025-03-11Annual report on Form 10-K filed with the SEC
2025-03-20Proxy solicitation materials are being sent to shareholders
2025-04-302025 Annual Meeting of Shareholders
2025-11-20Deadline to submit a shareholder proposal for the 2026 Annual Meeting
2025-12-31Earliest date to submit a proposal at our 2026 Annual Meeting
2026-01-30Latest date to submit a proposal at our 2026 Annual Meeting
2026-04-30Anticipated date of 2026 Annual Meeting of Shareholders
2029Next vote on the frequency of the say on pay vote will be held at the 2029 Annual Meeting

Keywords

shareholders, directors, compensation, governance, proxy statement, annual meeting, executive officers, audit committee, stock ownership, Nature's Sunshine Products

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.